You are here

  • Home
  • Archive
  • Volume 12, Issue 12
  • Rapamycin and inulin for third-dose vaccine response stimulation (RIVASTIM): Inulin – study protocol for a pilot, multicentre, randomised, double-blinded, controlled trial of dietary inulin to improve SARS-CoV-2 vaccine response in kidney transplant reci…

Citation Tools

Article menu
Renal medicine
Protocol
Rapamycin and inulin for third-dose vaccine response stimulation (RIVASTIM): Inulin – study protocol for a pilot, multicentre, randomised, double-blinded, controlled trial of dietary inulin to improve SARS-CoV-2 vaccine response in kidney transplant recipients

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Singer J, Tunbridge M, Perkins GB, et al
Rapamycin and inulin for third-dose vaccine response stimulation (RIVASTIM): Inulin – study protocol for a pilot, multicentre, randomised, double-blinded, controlled trial of dietary inulin to improve SARS-CoV-2 vaccine response in kidney transplant recipients
BMJ Open 2022;12:e062747. doi: 10.1136/bmjopen-2022-062747